Current Controlled Trials - Search the ISRCTN Register of Clinical Trials.

Welcome

12 February 2012

	Trial registration
	Unique identification scheme
	International databases

Find trials

ISRCTN Register

Registration

New application

Updating record

Information

introduction

governing board

ISRCTN FAQs

data set

guidance notes

International Standard Randomised Controlled Trial Number Register

Showing records: 5701 to 5710 of 10349

SEARCH FOR	RESULTS ORDER	DIRECTION	MAX RESULTS

5701	Comparison of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for treatment of uncomplicated malaria in Uganda: evaluation of efficacy, safety, and tolerability
	ISRCTN:	ISRCTN75606663
	Sponsor:	Uganda Malaria Surveillance Project (Uganda)
	Date assigned:	17 August 2006

5702	Evaluation of an algorithm for intensive subcutaneous insulin therapy in emergency room patients with hyperglycaemia
	ISRCTN:	ISRCTN55224894
	Sponsor:	University Hospital of Basel (Switzerland)
	Date assigned:	17 August 2006

5703	Creating A Peaceful School Learning Environment
	ISRCTN:	ISRCTN15430198
	Sponsor:	The Menninger Clinic (USA)
	Date assigned:	17 August 2006

5704	Indications for and consequences of antiepileptic drug withdrawal
	ISRCTN:	ISRCTN28271641
	Sponsor:	Akershus University Hospital (Norway)
	Date assigned:	17 August 2006

5705	A prospective randomised phase III trial of early hospital discharge versus standard inpatient management of cancer patients with low-risk febrile neutropenia receiving oral antibiotics
	ISRCTN:	ISRCTN18467252
	Sponsor:	University of Birmingham (UK)
	Date assigned:	17 August 2006

5706	The effects of a herbal combination on menopausal symptomatology
	ISRCTN:	ISRCTN98972974
	Sponsor:	RMIT University (Australia)
	Date assigned:	17 August 2006

5707	Hernia Umbilicalis Mesh versus Primary suture
	ISRCTN:	ISRCTN12851811
	Sponsor:	Erasmus Medical Center (The Netherlands)
	Date assigned:	17 August 2006

5708	Allopurinol in the prevention of superficial bladder tumour recurrence
	ISRCTN:	ISRCTN65811336
	Sponsor:	Leicester General Hospital (UK)
	Date assigned:	17 August 2006

5709	A Phase II, open-label study to evaluate the safety, tolerability, and pharmacokinetic profile of Proxinium™ in patients with recurrent squamous cell carcinoma of the head and neck who have received at least one prior anti-cancer treatment regimen for recurrent disease
	ISRCTN:	ISRCTN81721411
	Sponsor:	Viventia Biotech Inc (Canada)
	Date assigned:	17 August 2006

5710	Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction. A three-year randomised double-blind placebo-controlled international multicentre study
	ISRCTN:	ISRCTN70429960
	Sponsor:	Institut de Recherches Internationales Servier (France)
	Date assigned:	14 August 2006

RESULT PAGE

571


© 2012 ISRCTN unless otherwise stated.